LEXICON PHARMACEUTICALS, INC. Basic Shares Outstanding (Weighted Average)
LEXICON PHARMACEUTICALS, INC. (LXRX) reported Basic Shares Outstanding (Weighted Average) of 437.65 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-06
- LEXICON PHARMACEUTICALS, INC. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 437.65M shares, a 20.47% increase year-over-year.
- LEXICON PHARMACEUTICALS, INC. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 400.24M shares, a 10.54% increase year-over-year.
- LEXICON PHARMACEUTICALS, INC. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 363.43M shares, a 0.45% increase year-over-year.
- LEXICON PHARMACEUTICALS, INC. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 363.40M shares, a 0.53% increase year-over-year.
- LEXICON PHARMACEUTICALS, INC. weighted average number of shares outstanding, basic for fiscal 2025 was 363.05M shares, a 13.44% increase from fiscal 2024.
- LEXICON PHARMACEUTICALS, INC. weighted average number of shares outstanding, basic for fiscal 2024 was 320.03M shares, a 44.73% increase from fiscal 2023.
- LEXICON PHARMACEUTICALS, INC. weighted average number of shares outstanding, basic for fiscal 2023 was 221.13M shares, a 33.43% increase from fiscal 2022.
- LEXICON PHARMACEUTICALS, INC. weighted average number of shares outstanding, basic for fiscal 2022 was 165.73M shares, a 13.79% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | 437.65M shares 10-Q · filed 2026-08-06 | 419.05M shares 10-Q · filed 2026-08-06 | 400.44M shares derived: average of 3 quarters · filed 2026-08-06 | 391.18M shares derived: average of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | 400.24M shares 10-Q · filed 2026-05-07 | 381.84M shares derived: average of 2 quarters · filed 2026-05-07 | 375.69M shares derived: average of 3 quarters · filed 2026-05-07 | 372.59M shares derived: average of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | 363.43M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | 363.42M shares derived: average of 2 quarters · filed 2026-03-05 | 363.37M shares derived: average of 3 quarters · filed 2026-08-06 | 363.05M shares 10-K · filed 2026-03-05 |
| 2025-09-30 | 363.40M shares 10-Q · filed 2025-11-06 | 363.35M shares derived: average of 2 quarters · filed 2026-08-06 | 362.93M shares 10-Q · filed 2025-11-06 | 362.64M shares derived: average of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | 363.29M shares 10-Q · filed 2026-08-06 | 362.69M shares 10-Q · filed 2026-08-06 | 362.39M shares derived: average of 3 quarters · filed 2026-08-06 | 362.16M shares derived: average of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | 362.07M shares 10-Q · filed 2026-05-07 | 361.94M shares derived: average of 2 quarters · filed 2026-05-07 | 361.79M shares derived: average of 3 quarters · filed 2026-05-07 | 349.05M shares derived: average of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | 361.80M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | 361.64M shares derived: average of 2 quarters · filed 2026-03-05 | 344.71M shares derived: average of 3 quarters · filed 2026-03-05 | 320.03M shares 10-K · filed 2026-03-05 |
| 2024-09-30 | 361.49M shares 10-Q · filed 2025-11-06 | 336.16M shares derived: average of 2 quarters · filed 2025-11-06 | 306.11M shares 10-Q · filed 2025-11-06 | 290.73M shares derived: average of 4 quarters · filed 2026-03-05 |
| 2024-06-30 | 310.84M shares 10-Q · filed 2025-08-06 | 278.11M shares 10-Q · filed 2025-08-06 | 267.14M shares derived: average of 3 quarters · filed 2026-03-05 | 261.58M shares derived: average of 4 quarters · filed 2026-03-05 |
| 2024-03-31 | 245.39M shares 10-Q · filed 2025-05-14 | 245.29M shares derived: average of 2 quarters · filed 2026-03-05 | 245.17M shares derived: average of 3 quarters · filed 2026-03-05 | 235.07M shares derived: average of 4 quarters · filed 2026-03-05 |
| 2023-12-31 | 245.18M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | 245.05M shares derived: average of 2 quarters · filed 2026-03-05 | 231.63M shares derived: average of 3 quarters · filed 2026-03-05 | 221.13M shares 10-K · filed 2026-03-05 |
| 2023-09-30 | 244.93M shares 10-Q · filed 2024-11-13 | 224.85M shares derived: average of 2 quarters · filed 2024-11-13 | 213.11M shares 10-Q · filed 2024-11-13 | 206.93M shares derived: average of 4 quarters · filed 2025-03-07 |
| 2023-06-30 | 204.78M shares 10-Q · filed 2024-08-02 | 196.94M shares 10-Q · filed 2024-08-02 | 194.26M shares derived: average of 3 quarters · filed 2025-03-07 | 189.42M shares derived: average of 4 quarters · filed 2025-03-07 |
| 2023-03-31 | 189.01M shares 10-Q · filed 2024-05-02 | 189.00M shares derived: average of 2 quarters · filed 2025-03-07 | 184.30M shares derived: average of 3 quarters · filed 2025-03-07 | 175.63M shares derived: average of 4 quarters · filed 2025-03-07 |
| 2022-12-31 | 188.98M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-07 | 181.94M shares derived: average of 2 quarters · filed 2025-03-07 | 171.17M shares derived: average of 3 quarters · filed 2025-03-07 | 165.73M shares 10-K · filed 2025-03-07 |
| 2022-09-30 | 174.90M shares 10-Q · filed 2023-11-08 | 162.26M shares derived: average of 2 quarters · filed 2023-11-08 | 157.98M shares 10-Q · filed 2023-11-08 | 155.65M shares derived: average of 4 quarters · filed 2024-03-25 |
| 2022-06-30 | 149.62M shares 10-Q · filed 2023-08-04 | 149.38M shares 10-Q · filed 2023-08-04 | 149.23M shares derived: average of 3 quarters · filed 2024-03-25 | 148.38M shares derived: average of 4 quarters · filed 2024-03-25 |
| 2022-03-31 | 149.15M shares 10-Q · filed 2023-05-04 | 149.04M shares derived: average of 2 quarters · filed 2024-03-25 | 147.97M shares derived: average of 3 quarters · filed 2024-03-25 | 147.09M shares derived: average of 4 quarters · filed 2024-03-25 |
| 2021-12-31 | 148.93M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-25 | 147.38M shares derived: average of 2 quarters · filed 2024-03-25 | 146.40M shares derived: average of 3 quarters · filed 2024-03-25 | 145.65M shares 10-K · filed 2024-03-25 |
| 2021-09-30 | 145.82M shares 10-Q · filed 2022-11-09 | 145.14M shares derived: average of 2 quarters · filed 2022-11-09 | 144.56M shares 10-Q · filed 2022-11-09 | |
| 2021-06-30 | 144.45M shares 10-Q · filed 2022-08-03 | 143.92M shares 10-Q · filed 2022-08-03 | ||
| 2021-03-31 | 143.38M shares 10-Q · filed 2022-05-05 | |||
| 2020-09-30 | 107.31M shares 10-Q · filed 2021-11-09 | 107.19M shares derived: average of 2 quarters · filed 2021-11-09 | 106.97M shares 10-Q · filed 2021-11-09 | |
| 2020-06-30 | 107.07M shares 10-Q · filed 2021-08-06 | 106.80M shares 10-Q · filed 2021-08-06 | ||
| 2020-03-31 | 106.54M shares 10-Q · filed 2021-05-06 | |||
| 2019-09-30 | 106.27M shares 10-Q · filed 2020-10-30 | 106.27M shares derived: average of 2 quarters · filed 2020-10-30 | 106.20M shares 10-Q · filed 2020-10-30 | |
| 2019-06-30 | 106.27M shares 10-Q · filed 2020-07-29 | 106.16M shares 10-Q · filed 2020-07-29 | ||
| 2019-03-31 | 106.05M shares 10-Q · filed 2020-04-27 | |||
| 2018-09-30 | 105.88M shares 10-Q · filed 2019-11-07 | 105.80M shares 10-Q · filed 2019-11-07 | ||
| 2015-12-31 | 103.62M shares 10-K · filed 2017-03-06 | 103.62M shares derived: average of 2 quarters · filed 2017-03-06 | 103.62M shares derived: average of 3 quarters · filed 2017-03-06 | 103.59M shares derived: average of 4 quarters · filed 2017-03-06 |
| 2015-09-30 | 103.62M shares 10-K · filed 2017-03-06 | 103.61M shares derived: average of 2 quarters · filed 2017-03-06 | 103.58M shares derived: average of 3 quarters · filed 2017-03-06 | |
| 2015-06-30 | 103.61M shares 10-K · filed 2017-03-06 | 103.56M shares derived: average of 2 quarters · filed 2017-03-06 | ||
| 2015-03-31 | 103.52M shares 10-K · filed 2017-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |